Notice of Intent to Publish a Funding Opportunity Announcement for Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
ID: 356203Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $250K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356203
Timeline
    Description

    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the grant titled "Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)." This initiative aims to enhance access to secure and comprehensive datasets and computational models that facilitate transformative biomedical discoveries, emphasizing the need for innovative computational methods to improve data curation processes in light of the increasing volume of biomedical data. The anticipated funding amount for this grant is up to $250,000, with the announcement expected in Fall 2024 and the first application deadline set for February 5, 2025. Interested applicants are encouraged to prepare collaborative projects in advance of the official announcement.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Computational Approaches to Curation at Scale for Biomedical Research Assets" (R01 Clinical Trial Not Allowed) to enhance access to secure and complete biomedical datasets and computational models. The initiative aims to develop innovative computational methodologies that automate curation processes, addressing the increasing demand for curated, FAIR (Findable, Accessible, Interoperable, Reusable) biomedical data essential for data mining and knowledge discovery. Eligible applicants include various institutions such as higher education, nonprofits, and government entities, with a maximum project budget of $250,000 annually for up to four years. Applications are due by 5:00 PM local time, with the first submission window opening on December 27, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "Investigator Initiated Research in Computational Genomics and Data Science" (R01 Clinical Trial Not Allowed) aimed at advancing research in computational genomics, data science, and bioinformatics with applications to human health and disease. This initiative encourages innovative research efforts that enhance analytical methodologies, develop software tools, and improve genomic data management, with a focus on creating scalable solutions for increasingly large datasets. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and for-profit entities, with no cost-sharing requirement and a maximum budget of $500,000 in direct costs for projects not exceeding five years. Interested applicants should submit their proposals by January 7, 2025, and can direct inquiries to grantsinfo@nih.gov for further assistance.
    Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-stage Biomedical Data Repositories and Knowledgebases," aimed at supporting the development of new or significantly modified data repositories and knowledgebases that enhance biomedical research. This initiative encourages applications from a diverse range of eligible organizations, including higher education institutions and non-profits, with a funding cap of $350,000 per year for a maximum project duration of four years. The importance of this funding lies in its potential to align with FAIR data principles, thereby improving the ecosystem for biomedical research. Interested applicants should note that the application period opens on September 30, 2023, with a Notice of Award expected by early 2024; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at advancing research in computational genomics, bioinformatics, and data visualization methodologies that enhance genomic science and its application to human health. This initiative seeks innovative projects that develop novel analytical tools and methodologies, with a budget limit of $275,000 for a two-year project period, focusing on scalable solutions applicable across various diseases and biological systems. The funding is particularly targeted at underrepresented entities in genomic research, including higher education institutions, nonprofits, and governmental bodies, reflecting NIH's commitment to fostering collaborative research in this critical field. Interested applicants should note that key submission dates begin on January 16, 2025, with a final expiration date of September 8, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics, data science, and bioinformatics. This grant seeks to enhance analytical methodologies, develop and refine software tools, and integrate various genomic data types to improve human health outcomes, with a focus on applications that are broadly applicable across diseases and biological systems. Eligible applicants include a diverse range of organizations, particularly those from underrepresented groups in genomic science, and must adhere to strict application guidelines, including the submission of a Data Management and Sharing Plan. The application deadline is January 7, 2025, and interested parties can find more information and submit their applications electronically through Grants.gov or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required). This initiative aims to provide statistical expertise for the design, conduct, and data management of multi-center clinical trials, particularly focusing on late-phase treatment trials across various cancer types and patient demographics. The funding, estimated at $47 million, will support approximately five awards, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, interested applicants should prepare their proposals in advance of the anticipated timeline.
    NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering research grants through the National Library of Medicine (NLM) focused on biomedical informatics and data science, as outlined in funding opportunity announcement PAR-23-034. This initiative aims to support innovative research that enhances biomedical discovery and health data management, emphasizing scalable and reproducible methods that adhere to FAIR standards (Findable, Accessible, Interoperable, Reusable). Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and government agencies, with an annual budget limit of $250,000 over a maximum project period of four years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for research aimed at accelerating the pace of substance use research using existing data, specifically under the R01 grant mechanism. This initiative seeks to promote innovative research projects that leverage existing datasets to enhance understanding and treatment of substance use disorders, with the goal of fostering meaningful collaborations among researchers. The estimated total program funding is $2 million, with approximately three awards expected to be made, and the anticipated application due date is in Spring 2025, following the publication of the Notice of Funding Opportunity in Fall 2024. For further details, potential applicants should prepare to submit their proposals by the estimated close date of June 17, 2025, with awards expected to be announced by April 1, 2026.